Increased levels of BMP2 (which drives CSC differentiation toward post-mitotic cancer cells) have been detected in GBM tumors; however, these tumors still retain a subpopulation of pluripotent CSCs, despite high BMP2 expression [9]. This evidence concerns the gene BMP2 and cancer.